COVID-19 has had devastating effects on health systems and economies across the world and has put the importance of the prevention of ill health throughout the life course into sharp focus– from the importance of better pandemic preparedness to the need to promote the overall health of the population. This ILC webinar is part of our “Delivering prevention in an ageing world” programme. The panellists presented their country perspectives on how each of their countries have responded to COVID-19 and what we can learn from the pandemic for the prevention agenda going forward.

1. Under the microscope
Comparing countries’ experiences
of the COVID-19 pandemic
@ilcuk
#DeliveringPrevention

2. @ilcuk
#DeliveringPrevention
About ILC
We are the UK’s specialist think
tank on the impact of longevity
on society, and what happens
next.
We are one of the founding
members of the ILC Global
Alliance, an international
network on longevity with
members across 16 countries.

3. Welcome from Chair
Kate Pierpoint, Head of Projects, ILC
@ilcuk
#DeliveringPrevention

4. Delivering prevention
Why we’re looking at COVID-19
Lily Parsey, Global Policy and Influencing
Manager, ILC
@ilcuk
#DeliveringPrevention

5. It’s never too late to prevent
27.1 million years
were lived with disability due to largely
preventable age-related conditions in 2017 in
better off countries.
Time spent in poor health is set to increase by
17% over the next 25 years.

6. The costs of failing to act are too high to
ignore
692 billion USD
yearly productivity loss as a result of largely preventable age-related conditions

7. The costs of failing to act are too high to
ignore
Planning to add some stats from GLD and
Les’ report here too

8. The costs of failing to act are too high to
ignore
Planning to add some stats from GLD and
Les’ report here too

9. Moving from “why” to “how”

10. Delivering prevention in an ageing
world

11. COVID-19 has shown us we need to act
now
• COVID-19 has impacted on our health
• Direct impact on health
• Impact on health systems
• Impact on non-COVID related conditions
• COVID-19 has impacted on our economy
• Many advanced economies experienced double-digit declines in gross domestic product (GDP) in the first half of 2020 (ONS)
• In 2020, 8.8 per cent of global working hours were lost relative to the fourth quarter of 2019, equivalent to 255 million full-
time jobs. (ILO)
• Much of Europe is expected to take nearly 3 years to recover. In Mexico and South Africa, it could take between 3 and 5 years.
(OECD)
• COVID-19 has impacted on all of us as individuals

12. COVID-19 has shown us we need to act
now
As of 10:12am CEST, 30 June 2021

13. @ilcuk
#DeliveringPrevention
What we’ve seen so far
Arun Himawan, Research Fellow, ILC

14. Democratise access
• Improving access to testing, vaccines and healthcare services.
• Supporting at-risk and underserved groups by tailoring health
services.
• Making access to health services free of charge.
• Promoting health literacy and population health.

15. Inspire and engage people with
prevention
• Global and national collaboration and coordination.
• Healthcare integration to alleviate the burden placed on health
services.
• Supporting and maximising the role of healthcare professionals.
• Changing the message and the messenger to improve to encourage
and improve adherence to uptake of public health measures.
• Using behavioural economics to support self-isolation.

16. Using technology effectively
• Using big data to improve population health.
• Connecting individuals to preventative healthcare through
telehealth technologies.
• Supporting healthcare delivery.
• Empowering individuals (by improving health literacy and
addressing barriers to digital health exclusion).

17. How New Zealand
responded to
COVID-19
Hon Andrew Little MP
, New Zealand Minister of Health
Presentation to International Longevity Centre UK
31 June 2021
Authorised by Hon Andrew Little MP, Parliament Buildings, Wellington, New Zealand

18. Strategy
 Overall strategy is elimination. That is, to apply a range of control measures to stop the
transmission of COVID-19.
 Elimination does not mean eradicating the virus permanently from New Zealand; rather
it is being confident we have eliminated chains of transmission in our community for at
least 28 days and can effectively contain any future imported cases from overseas.
 We do this through:
 controlling entry at the border
 disease surveillance
 hygiene measures including physical distancing where needed
 testing for and tracing all potential cases
 isolating cases and their close contacts
 broader public health controls when needed

19. Features
 Going hard and going early, including with income and business support
 Whanaungatanga of the Team of Five Million
 Four clear Alert Levels
 Single source of clear, trusted information at www.covid19.govt.nz
 Regular updates from Prime Minister
Jacinda Ardern and Director-General of
Health Dr Ashley Bloomfield
 QR code scanning, national emergency mobile
alert system, gold standard contact tracing
 Free 2-dose Pfizer vaccine for everyone aged 16+,
currently provisionally approved for 12-15 year olds

20. Results – there is no COVID-19 in the
community in New Zealand

21. Q&A
Please submit your questions via the Q&A tab
@ilcuk
#DeliveringPrevention

22. P r o f. C h i e n - w e n M a r k S h e n
N a t i o n a l C e n t r a l U n i v e r s i t y,
Ta i w a n

23. 23

24. Key Success Factors in Early Stage
• Wear mask with
sufficient supplies
• Monitor temperature
and provide hand
sanitizers in major
public areas
• 14-day quarantine for
inbound travelers

30. Q&A

31. Under the microscope: Comparing countries’
experiences of the COVID-19 pandemic
Fast & Determined: How Israel successfully
implemented vaccination roll-out and monitoring
Prof. Itamar Grotto, Public Health Physician, Professor of Epidemiology
Former Associate Director General, Israel Ministry of Health

32. Israeli
COVID-19
Vaccine Drive:
Safe
Simple
Flexible
Accessible

33. Covid-19
in Israel
Reducing restrictions
- opening of trade,
culture & dining
120K PCR
tests daily
– at peak
≈9%
Infected since start
of the pandemic
6,429
Fatalities
23
Current severe
cases

34. Vaccination
current status
90%
Of 50+ age
group are
vaccinated
Vaccination of
children aged 12-16
was added recently
5.5M
Vaccinated

35. Key Principles
Vaccinating as fast as possible by HMOs to reduce
morbidity and mortality
Monitoring Effectiveness and Tracking side effects
Marketing and fighting fake news to encourage vaccine
compliance
Simple prioritization: initially aged 60+, medical staff, first
responders (now 16+ excluding recovered patients)

36. “New” vaccine with Emergency Authorization
The first country to operate a mass vaccination campaign
Risk Communication Challenges
“General” Vaccine Hesitancy
COVID 19 Specific implications of the level of trust between governments and
the public
“Infodemic” – Fake news mainly on social networks

37. Citizen Engagement Digital Tools
HaMagen (The Shield) App
Inform whether the app user might have been
exposed to a confirmed COVID-19 patient
Remote screening for concerned patients
Personalized guidance to patients based on a thorough self-
assessment
CoronApp & Telegram
Official Communication channels

38. Health
Information
Exchange
 Interoperability
 Continuum of Data
 Comprehensive
Database
Ofek

40. Passive and active surveillance of side effects
Weekly publication of aggregative reports
Monitoring Effectiveness
• MoH: National level; specific populations, linkage of national databases
• HMO’s: Using their own data-bases
Publication of effectiveness data:
• Scientific articles
• Public Reports
Safety and Effectiveness Monitoring and Transparency

41. Age Adjusted vaccine effectiveness (Feb 13, 2021)
14 days after 2nd dose
7 days after 2nd dose
Effectiveness
95.8%
91.9%
Total cases
98.0%
96.9%
Symptomatic disease
98.9%
95.6%
Hospitalization
99.2%
96.4%
Severe cases
98.9%
94.5%
Mortality

42. Call center for vaccination professionals –
administration guidance, clinical questions, and
shipment information
Need to create smaller cases for distribution
Training EMTs and Paramedics to administer
the vaccine has added surge capacity
Lessons
Learned

43. Monitoring effectiveness and Side-effect tracking
Documentation and the green pass program
Trustable risk communication led by proffesionals
Technological tools were vital in targeting patients
through integrated National Immunization
Registry and HMO EMRs and communications
systems
Lessons
Learned
Lessons
Learned

44. Green
Pass
Program

45. Outcome

46. Q&A
Please submit your questions via the Q&A tab
@ilcuk
#DeliveringPrevention

47. Closing remarks
Kate Pierpoint, Head of Projects, ILC
@ilcuk
#DeliveringPrevention

48. Webinar: Data, bots and drones – Transforming access to
health through technology
Register at ilcuk.org.uk/events
@ilcuk
#DigitalHealth
Date: Tuesday, 6 July 2021
Time: 2.00pm – 3.30pm BST (3.00pm – 4.30pm CEST)
Chair: Gary Finnegan (Vaccines Today)
Speakers: Dr Wendy Yared (Association of European Cancer Leagues), Daphne Holt
(Coalition for Life-Course Immunisation), Prof Eerke Boiten (De Montfort University),
Philip Weiss (ZN Consulting), Sibilia Quilici (Vaccines Europe)

49. COVID-19 in the UK and US: Understanding the impact on
insurance, retirement income and other financial services risks
Register at ilcuk.org.uk/events
@ilcuk
#WhatHappensNext
Chair: Trevor Llanwarne (ILC Trustee)
Speakers: Nicola Oliver (Medical Intelligence), Caroline Roberts (The Phoenix Group), Douglas
Anderson (Club Vita), Anna Rappaport (Society of Actuaries Aging and Retirement Steering
Committee), Max Rudolph (Rudolph Financial Consulting), Ed Pudlowski (MorningStar Actuarial
Consulting), Matt Gurden (Government Actuary's Department)
Date: Thursday, 15 July 2021
Time: 2.00pm – 4.00pm BST (9.00am – 11.00am EDT)

50. Future of Ageing 2021: Reimagining
ageing in a changing world
Register at
http://futureofageing.org.uk/
@ilcuk
#FutureOfAgeing
Date: Thursday, 2 December 2021
Time: 9.00am – 5.00pm GMT
Location: Wellcome Collection, London

51. @ilcuk
#DeliveringPrevention
Thank you